150 related articles for article (PubMed ID: 18781936)
1. A rescue factor for Alzheimer's diseases: discovery, activity, structure, and mechanism.
Arakawa T; Kita Y; Niikura T
Curr Med Chem; 2008; 15(21):2086-98. PubMed ID: 18781936
[TBL] [Abstract][Full Text] [Related]
2. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults.
Hashimoto Y; Niikura T; Ito Y; Sudo H; Hata M; Arakawa E; Abe Y; Kita Y; Nishimoto I
J Neurosci; 2001 Dec; 21(23):9235-45. PubMed ID: 11717357
[TBL] [Abstract][Full Text] [Related]
3. Two serine residues distinctly regulate the rescue function of Humanin, an inhibiting factor of Alzheimer's disease-related neurotoxicity: functional potentiation by isomerization and dimerization.
Terashita K; Hashimoto Y; Niikura T; Tajima H; Yamagishi Y; Ishizaka M; Kawasumi M; Chiba T; Kanekura K; Yamada M; Nawa M; Kita Y; Aiso S; Nishimoto I
J Neurochem; 2003 Jun; 85(6):1521-38. PubMed ID: 12787071
[TBL] [Abstract][Full Text] [Related]
4. Interaction structure of the complex between neuroprotective factor humanin and Alzheimer's β-amyloid peptide revealed by affinity mass spectrometry and molecular modeling.
Maftei M; Tian X; Manea M; Exner TE; Schwanzar D; von Arnim CA; Przybylski M
J Pept Sci; 2012 Jun; 18(6):373-82. PubMed ID: 22522311
[TBL] [Abstract][Full Text] [Related]
5. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo.
Chiba T; Yamada M; Hashimoto Y; Sato M; Sasabe J; Kita Y; Terashita K; Aiso S; Nishimoto I; Matsuoka M
J Neurosci; 2005 Nov; 25(44):10252-61. PubMed ID: 16267233
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein.
Hashimoto Y; Ito Y; Niikura T; Shao Z; Hata M; Oyama F; Nishimoto I
Biochem Biophys Res Commun; 2001 May; 283(2):460-8. PubMed ID: 11327724
[TBL] [Abstract][Full Text] [Related]
7. Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection.
Hashimoto Y; Suzuki H; Aiso S; Niikura T; Nishimoto I; Matsuoka M
Life Sci; 2005 Oct; 77(24):3092-104. PubMed ID: 16005025
[TBL] [Abstract][Full Text] [Related]
8. Humanin: after the discovery.
Niikura T; Chiba T; Aiso S; Matsuoka M; Nishimoto I
Mol Neurobiol; 2004 Dec; 30(3):327-40. PubMed ID: 15655255
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease.
Benaki D; Zikos C; Evangelou A; Livaniou E; Vlassi M; Mikros E; Pelecanou M
Biochem Biophys Res Commun; 2006 Oct; 349(2):634-42. PubMed ID: 16945331
[TBL] [Abstract][Full Text] [Related]
10. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice.
Tajima H; Kawasumi M; Chiba T; Yamada M; Yamashita K; Nawa M; Kita Y; Kouyama K; Aiso S; Matsuoka M; Niikura T; Nishimoto I
J Neurosci Res; 2005 Mar; 79(5):714-23. PubMed ID: 15678515
[TBL] [Abstract][Full Text] [Related]
11. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor.
Ying G; Iribarren P; Zhou Y; Gong W; Zhang N; Yu ZX; Le Y; Cui Y; Wang JM
J Immunol; 2004 Jun; 172(11):7078-85. PubMed ID: 15153530
[TBL] [Abstract][Full Text] [Related]
12. ["Death and survival of neuronal cells exposed to Alzheimer's disease-relevant insults"].
Nishimoto I
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):11P-15P. PubMed ID: 12491768
[TBL] [Abstract][Full Text] [Related]
13. Active form of neuroprotective Humanin, HN, and inactive analog, S7A-HN, are monomeric and disordered in aqueous phosphate solution at pH 6.0; No correlation of solution structure with activity.
Arisaka F; Arakawa T; Niikura T; Kita Y
Protein Pept Lett; 2009; 16(2):132-7. PubMed ID: 19200035
[TBL] [Abstract][Full Text] [Related]
14. Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats.
Chai GS; Duan DX; Ma RH; Shen JY; Li HL; Ma ZW; Luo Y; Wang L; Qi XH; Wang Q; Wang JZ; Wei Z; Mousseau DD; Wang L; Liu G
Neurosci Bull; 2014 Dec; 30(6):923-935. PubMed ID: 25391447
[TBL] [Abstract][Full Text] [Related]
15. [Recent progress in neuroprotection of humanin against Alzheimer's disease-relevant neurotoxicity].
Cui AL; Zhao L; Li LM; Qiao JT; Zhang C
Sheng Li Ke Xue Jin Zhan; 2006 Oct; 37(4):302-6. PubMed ID: 17262962
[TBL] [Abstract][Full Text] [Related]
16. Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer's disease-relevant insults.
Yamagishi Y; Hashimoto Y; Niikura T; Nishimoto I
Peptides; 2003 Apr; 24(4):585-95. PubMed ID: 12860203
[TBL] [Abstract][Full Text] [Related]
17. Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity.
Jung SS; Van Nostrand WE
J Neurochem; 2003 Jan; 84(2):266-72. PubMed ID: 12558989
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of humanin on okadaic Acid-induced neurotoxicities in cultured cortical neurons.
Zhao J; Wang D; Li L; Zhao W; Zhang C
Neurochem Res; 2014 Nov; 39(11):2150-9. PubMed ID: 25142935
[TBL] [Abstract][Full Text] [Related]
19. Humanin and colivelin: neuronal-death-suppressing peptides for Alzheimer's disease and amyotrophic lateral sclerosis.
Matsuoka M; Hashimoto Y; Aiso S; Nishimoto I
CNS Drug Rev; 2006; 12(2):113-22. PubMed ID: 16958985
[TBL] [Abstract][Full Text] [Related]
20. Novel humanin analogs confer neuroprotection and myoprotection to neuronal and myoblast cell cultures exposed to ischemia-like and doxorubicin-induced cell death insults.
Gilon C; Gitlin-Domagalska A; Lahiani A; Yehoshua-Alshanski S; Shumacher-Klinger A; Gilon D; Taha M; Sekler I; Hoffman A; Lazarovici P
Peptides; 2020 Dec; 134():170399. PubMed ID: 32889021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
